The European Medicines
Agency has released its first
product-specific guidance on the
demonstration of bioequivalence
for 16 active substances.
It’s the first wave of product-specific
bioequivalence guidance,
with the aim of enabling a
consistent approach to the
assessment of applications
supported by bioequivalence data,
particularly generic applications,
across all authorisation routes.
The guidance documents have
been released for a three month
public consultation - CL ICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Nov 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Nov 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.